Stocks
iShares Biotechnology ETFIBB
NASDAQHealthcareBiotechnology$165.51-0.43%
Price as of · delayed, not real-time
An exchange-traded fund that provides exposure to U.S. biotechnology companies, offering investors diversified access to firms engaged in drug development, medical devices, and genetic research. It is widely tracked as a benchmark for the biotech sector due to its broad market coverage and liquidity.
Market Cap: $8.0B52W Range: $107.43 – $179.64
Congressional Interest in iShares Biotechnology ETF (IBB)
9 members of Congress have disclosed 12 trades in iShares Biotechnology ETF (IBB), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
9
Buys
4
Sells
8
Who in Congress Is Trading IBB?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-02-23 | DAVID P. JOYCE | sell | $1K – $15K |
| 2017-02-17 | DAVID P. JOYCE | sell | $1K – $15K |
| 2016-12-30 | Carlos Curbelo | sell | $1K – $15K |
| 2016-12-28 | Richard L. Hanna | sell | $1K – $15K |
| 2016-05-31 | JAMES FRENCH HILL | buy | $15K – $50K |
| 2016-05-25 | Carlos Curbelo | buy | $1K – $15K |
| 2015-08-13 | DAVID P. JOYCE | buy | $1K – $15K |
| 2012-03-10 | JAMES B. RENACCI | buy | $23,912.00 |
| 2011-02-06 | CAROLYN MCCARTHY | sell | $3,190 |
| 2010-04-01 | BRAD MILLER | sell | $1,322.90 |
| 2007-11-06 | MICHAEL C. BURGESS | sell | $1 – $1K |
| 2005-06-11 | William R. Keating | sell | $15K – $50K |